PARVOVAX

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

PORCINE PARVOVIRUS INACTIVATED K-22 STRAIN

Available from:

Merial Animal Health Limited

ATC code:

QI09AA02

INN (International Name):

PORCINE PARVOVIRUS INACTIVATED K-22 STRAIN

Dosage:

Unknown

Pharmaceutical form:

Emulsion for Injection

Prescription type:

POM

Therapeutic group:

Porcine

Therapeutic area:

Porcine parvovirus vaccine

Therapeutic indications:

Immunological - Inactivated vaccine

Authorization status:

Authorised

Authorization date:

2002-11-06

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
PARVOVAX.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 HAI.U: q.s. to obtain HAI antibody titres of 1 log10 in guinea-pigs
after administration of the vaccine.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Emulsion for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Breeder pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For
active immunisation of
breeder
pigs (gilts,
sows,
boars)
against
porcine parvovirus,
to reduce the number
of
stillbirths and mummified foetuses in vaccinates.
The onset
of
immunity is obtained from 2 to 3 weeks after
the
primary vaccination. This immunity persists for up to one year.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate only healthy animals. Vaccinate sows during lactation.
Each 2-ml dose of vaccine contains:
Inactivated porcine parvovirus, minimum
2.0 HAI.U
Thiomersal, maximum
0.2 mg
Oily adjuvant which includes light paraffin oil
449.6 to 488.2 mg
Benzyl alcohol
10.56mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_6_
_/_
_0_
_2_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_8_
_5_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTRATING THE
MEDICINAL
PRODUCT TO ANIMALS
Apply usual aseptic procedures.
To the user:
This product contains mineral o